Pluri Inc. (TLV:PLUR)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,033.00
-10.00 (-0.96%)
At close: Jan 30, 2026
Pluri Market Cap
Pluri has a market cap or net worth of 107.56 million as of January 30, 2026. Its market cap has increased by 25.02% in one year.
Market Cap
107.56M
Enterprise Value
184.69M
Revenue
4.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,033.00
Market Cap Chart
Since April 16, 2003, Pluri's market cap has increased from 22.56M to 107.56M, an increase of 376.78%. That is a compound annual growth rate of 7.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 107.56M | 22.31% |
| Dec 31, 2025 | 87.94M | 1.56% |
| Dec 31, 2024 | 86.59M | 0.10% |
| Dec 29, 2023 | 86.50M | -19.87% |
| Dec 30, 2022 | 107.95M | -25.94% |
| Dec 31, 2021 | 145.77M | -74.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 434.47M |
| Geffen Residence & Renewal | 261.69M |
| Matricelf | 143.84M |
| Clal Biotechnology Industries | 48.47M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 34.65M |
| Evogene | 27.76M |
| XTL Biopharmaceuticals | 25.55M |